Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06553131 · ClinicalTrials.gov registry record
Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison
A clinical trial of Neuromuscular Blockade, sponsored by Loma Linda University.
- Recruiting
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT06553131: Recruiting study of Neuromuscular Blockade, sponsored by Loma Linda University.
NCT06553131 is a study of Neuromuscular Blockade that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 32 participants, below the 11,836-participant average among 6 other Neuromuscular Blockade trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06553131, a study of Neuromuscular Blockade, is actively recruiting participants, sponsored by Loma Linda University.
- RECRUITING
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Medications used to relax the muscles are used during surgery. The amount of muscle relaxation can monitored with devices that stimulate a specific nerve and evaluate the muscle response. The response to, and recovery from, medications that relax the muscles are best described for a nerve in the arm called the ulnar nerve. The investigators believe that other nerves in the arm, such as the median nerve, could be used to monitor the amount of muscle relaxation. The purpose of this study is to compare the muscle response at two different nerve sites after giving medications to relax the muscles. This study is going to measure the depth of muscle relaxation during surgery at two different sites. The muscle response to stimulation of the ulnar nerve (located in the arm) will be compared to the muscle response to stimulation of the median nerve (also located in the arm).
Primary Outcome
The length of time between rocuronium administration and first post-tetanic twitch for both nerves
Conditions Studied
Interventions
- DEVICE Neuromuscular Transmission Monitoring
Study Locations (1)
California
- Loma Linda University Troesch Medical Center - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-12-26 |
| Est. Completion | 2026-12 |
What NCT06553131 shows while recruiting
NCT06553131 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 11,836-participant average among 6 other Neuromuscular Blockade trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Neuromuscular Blockade appearing as the primary indexed condition, and to 1 intervention - of which Neuromuscular Transmission Monitoring is the first listed.
NCT06553131 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06553131 about?
NCT06553131 is a clinical study titled "Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison". Medications used to relax the muscles are used during surgery. The amount of muscle relaxation can monitored with devices that stimulate a specific nerve and evaluate the muscle response. The response to, and recovery from, medications that relax the muscles are best described for a nerve in the arm...
What is the current status of trial NCT06553131?
This trial is currently recruiting. The enrollment target is 32 participants. The study started on 2024-12-26. Estimated completion is 2026-12.
What conditions does trial NCT06553131 study?
This clinical trial studies the following conditions: Neuromuscular Blockade.
What interventions are being tested in trial NCT06553131?
The interventions under investigation include: Neuromuscular Transmission Monitoring (DEVICE).
Who is sponsoring clinical trial NCT06553131?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06553131 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuromuscular Blockade
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
RECRUITING · Phase 4
-
NMBA Reversal and Postoperative Urinary Retention
ACTIVE NOT RECRUITING
-
Understanding the Cognition and Decision Making of Community Anesthesiologists
COMPLETED
-
Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular
COMPLETED · Phase 4
-
Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring
COMPLETED
-
The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI